WINNING STRATEGIES WASHINGTON

Lobbying for I AM ALS · patient advocacy

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jul 16, 2026.

Filing Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 16, 2026

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Lobbyists on this filing 2

NANCY FOX

Previously held: Staff Director House Appropriations Committee, Chief of Staff Rep. Rodney Frelinghuysen (NJ) Scheduler Rep. Marge Roukema (NJ), Scheduler Rep. Silvio O. Conte (MA)
MICHAEL A MEROLA

Previously held: Deputy CoS, Sen. Torricelli

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Budget/Appropriations

Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills

Health Issues

Reauthorization of the Act for ALS; funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills; legislation related to the FDA; The ACT for ALS. Establishment and funding of ARPA-H, Ag/FDA

Medical/Disease Research/Clinical Labs

Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.